BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 18627476)

  • 1. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
    Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S
    Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Yang YP; Li W; Huang WM; Zhou Y; Fan YM
    Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
    Yang Y; Hu Y; Zhang J; Li X; Lu C; Liang Y; Xi L
    Med Mycol; 2012 Aug; 50(6):649-53. PubMed ID: 22309458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromoblastomycosis due to Fonsecaea monophora in a man with nephritic syndrome.
    Tan H; Xu Y; Lan XM; Wu YG; Zhou CJ; Yang XC
    Mycopathologia; 2015 Jun; 179(5-6):447-52. PubMed ID: 25575792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
    Hu Y; Huang X; Lu S; Hamblin MR; Mylonakis E; Zhang J; Xi L
    Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
    Queiroz-Telles F; Esterre P; Perez-Blanco M; Vitale RG; Salgado CG; Bonifaz A
    Med Mycol; 2009 Feb; 47(1):3-15. PubMed ID: 19085206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of chromoblastomycosis of 10-year duration due to Fonsecaea nubica.
    He L; Ma J; Mei X; Lu S; Li X; Xi L
    Mycoses; 2018 Apr; 61(4):231-236. PubMed ID: 29178398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora.
    Najafzadeh MJ; Rezusta A; Cameo MI; Zubiri ML; Yus MC; Badali H; Revillo MJ; De Hoog GS
    Med Mycol; 2010 Mar; 48(2):390-3. PubMed ID: 19488919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
    Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
    Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
    Calvo E; Pastor FJ; Mayayo E; Hernández P; Guarro J
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3709-13. PubMed ID: 21576429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromoblastomycosis.
    Torres-Guerrero E; Isa-Isa R; Isa M; Arenas R
    Clin Dermatol; 2012; 30(4):403-8. PubMed ID: 22682188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of chromoblastomycosis by Fonsecaea nubica indicating a possible insect route of transmission.
    Chen Y; Yin S; Li M; Chen R; Wei L; Ma H; Deng S; de Hoog GS; Lai W; Lu C; Feng P
    Mycoses; 2016 Oct; 59(10):662-7. PubMed ID: 27330038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular identification of chromoblastomycosis clinical isolates in Guangdong.
    Fransisca C; He Y; Chen Z; Liu H; Xi L
    Med Mycol; 2017 Nov; 55(8):851-858. PubMed ID: 28053146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chromoblastomycosis with terbinafine: a report of four cases.
    Xibao Z; Changxing L; Quan L; Yuqing H
    J Dermatolog Treat; 2005 Apr; 16(2):121-4. PubMed ID: 16019628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of chromomycosis treated by surgical therapy combined with preceded oral administration of terbinafine to reduce the size of the lesion.
    Tamura K; Matsuyama T; Yahagi E; Kojima T; Akasaka E; Kondo A; Ikoma N; Mabuchi T; Tamiya S; Ozawa A; Mochizuki T
    Tokai J Exp Clin Med; 2012 Apr; 37(1):6-10. PubMed ID: 22488556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil.
    Gupta AK; Taborda PR; Sanzovo AD
    Med Mycol; 2002 Oct; 40(5):529-34. PubMed ID: 12462534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chromoblastomycosis with terbinafine: experience with four cases.
    Bonifaz A; Saúl A; Paredes-Solis V; Araiza J; Fierro-Arias L
    J Dermatolog Treat; 2005 Feb; 16(1):47-51. PubMed ID: 15897168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
    Andrade TS; Castro LG; Nunes RS; Gimenes VM; Cury AE
    Mycoses; 2004 Jun; 47(5-6):216-21. PubMed ID: 15189187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Successful Treatment of Chromoblastomycosis Caused by
    Bao F; Wang Q; Yu C; Shang P; Sun L; Zhou G; Wu M; Zhang F
    Am J Trop Med Hyg; 2018 Jul; 99(1):124-126. PubMed ID: 29785921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
    Hu Y; Qi X; Sun H; Lu Y; Hu Y; Chen X; Liu K; Yang Y; Mao Z; Wu Z; Zhou X
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007849. PubMed ID: 31671098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.